In cancer, Nrf2 can recruit the E1A-binding protein p300 (EP300), thereby enhancing the H3K27 acetylation modification of SOD2, which counters oxidative stress and inhibits ferroptosis [266] (Fig. 7I, Upper-middle). Here, EP300 is linked to cancer.